Artisan Partners Form 8.3 - Allergan PLC
September 13 2019 - 8:55AM
UK Regulatory
TIDM0Y7T
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
Name of person dealing (Note 1) Artisan Partners Limited Partnership
Company dealt in Allergan PLC
Class of relevant security US$0.0001 ordinary shares
to which the dealings
being disclosed relate (Note 2)
Date of dealing September 12, 2019
2 .INTERESTS AND SHORT POSITIONS
Long Short
Number (%) Number (%)
(1) Relevant securities 4,639,927 1.41 0.00 0.00
(2) Derivatives (other than options) 0.00 0.00 0.00 0.00
(3) Options and agreements to purchase/sell 0.00 0.00 0.00 0.00
Total 4,639,927 1.41 0.00 0.00
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
Purchase/sale Number of relevant securities Price per unit (Note 5)
Sale 948 $166.50
Sale 13,500 $166.52
Sale 653,363 $166.64
Sale 102,000 $166.76
Sale 89,700 $166.77
Product name, Nature of transaction Number of relevant Price per unit
e.g. CFD (Note 6) securities (Note 5)
(Note 7)
Product Writing, Number Exercise Type, Expiry date Option
name, selling, of price e.g. money
e.g. call purchasing, securities American, paid/received
option varying etc. to which European per unit
the etc. (Note 5)
option
relates
(Note 7)
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this
should be stated.
Is a Supplemental Form 8 attached? (Note 9) YES/NO
Date of disclosure September 13, 2019
Contact name Jason Krueger
Telephone number 414-390-2008
If a connected EFM, name of offeree/offeror
with which connected
If a connected EFM, state nature
of connection (Note 10)
View source version on businesswire.com:
https://www.businesswire.com/news/home/20190913005302/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
September 13, 2019 09:55 ET (13:55 GMT)
Allergan (LSE:0Y7T)
Historical Stock Chart
From Apr 2024 to May 2024
Allergan (LSE:0Y7T)
Historical Stock Chart
From May 2023 to May 2024